Skip to content

Dr. Kirsten Riches-Suman

Associate Professor

Area
School of Chemistry & Biosciences
Faculty of Life Sciences
E-mail
Phone
Dr. Kirsten Riches-Suman

Biography

I studied undergraduate BSc (Hons) Biology (Molecular and Cellular) at the University of Huddersfield and graduated with first class honours in 2003. I then worked at the University of Bradford as a research technician until 2005, when I started my PhD in Cardiovascular Medicine at the University of Leeds under the supervision of Dr Karen Porter and Prof Chris Peers. My work during this time resulted in 3 publications and multiple awards at national and international conferences. After completing my PhD in early 2009, I worked as a post-doctoral research fellow in the Porter lab. This gave me essential training not only in various laboratory techniques, but also in composing grant applications, writing papers, establishing collaborations and supervising students. In November 2015 I started at the University of Bradford as a Lecturer in Biochemistry. In 2018 I graduated with a Postgraduate Certificate in Higher Education Practice (distinction) and was awarded fellowship of the Higher Education Academy. In 2018 I my specialism changed to Lecturer in Biomedical Science to better reflect the teaching that I undertake. 

Research

The prevalence of type 2 diabetes (T2DM) is growing at an alarming rate throughout the world, and new treatments are desperately needed to help these patients cope with the complications that come with T2DM. These patients have a much greater risk of developing cardiovascular disease, have poorer outcomes following cardiac surgery, and have problems with wound healing. All of this is very distressing for the patient and also has a big financial impact on the NHS. The over-arching theme of my research interests is how diabetes can impact on cell behaviour (‘phenotype’), and examine the molecular mechanisms underlying this. In the future, this will help us to design new therapies to improve the quality of life and care for patients with diabetes.

I have previously researched the phenotypic differences in cardiovascular cells that are involved in diabetic cardiomyopathy (cardiac fibroblasts) and coronary artery bypass graft surgery (smooth muscle and endothelial cells from veins). This work has identified molecular signatures of these phenotypes and work is currently been carried out both here (with Prof. Tim Palmer, Pharmacy) and with collaborators at the University of Leeds to further this understanding. I am now looking at a different form of diabetes - gestational diabetes (GDM) – and how this can affect the smooth muscle cells in the umbilical artery. GDM normally goes away once the baby is born, but both the mother and child are at an increased risk of developing T2DM. This is a very exciting piece of work; my previous studies all looked at cells from patients who had suffered from diabetes for a long period of time. In this GDM project, the maximum duration of diabetes will have been 9 months and so it will allow us to find out how quickly phenotypic changes can occur after the onset of diabetes.

Patients with T2DM have problems with wound healing so I am also interested in how the factors in the circulation of T2DM patients (such as high levels of glucose, free fatty acids, inflammatory mediators) may alter the phenotype of cells that are involved in wound healing. I am working with in the Centre for Skin Sciences to try and explain the molecular changes that underlie this phenomenon.

Research projects

Research collaborator

  • Embryology (University of Leeds)
  • Diabetes and Cardiovascular Disease (University of Bradford)
  • Skin Sciences (University of Bradford)
  • Diabetes and vascular disease (University of Leeds)
  • Cardiovascular disease (Hull York Medical School)
  • Diabetes cellular phenotyping (University of York)
  • Wound healing (Leeds Beckett University)
  • Diabetes and vascular disease (Bradford Royal Infirmary)

Teaching

My teaching interests are the biological basis of disease. This encompasses genetics, biochemistry and pathology of diseases such as cardiovascular disease and diabetes - their aetiology, presentation and treatment. I am passionate about engaging students in their teaching and as such use active learning techniques which have been flagged as examples of best practice by students. 

Professional activities

  • BSCR Early Career Investigator Award (1 June 2008)

  • School of Chemistry and Biosciences Research Committee, (1 September 2019)
  • School of Chemistry and Biosciences Equality, Diversity and Opportunities, (3 July 2017)
  • School of Chemistry and Biosciences Executive, (1 August 2016)
  • LICAMM Early Career Group, (1 January 2013)

  • University of Leeds - PhD
  • University of Huddersfield - BSc (Hons)
  • University of Bradford - Post-graduate Certificate in Higher Education Practice

  • University of Bradford - Lecturer in Biochemistry (1 January 2015)
  • University of Leeds - Post-doctoral Research Fellow (1 January 2008)
  • University of Bradford - Research Technician (1 January 2004)

  • Biochemical Society, Member
  • Northern Vascular Research Forum, Committee Member
  • Higher Education Academy, Fellow
  • Northern Cardiovascular Research Group, University of Bradford Representative
  • British Society for Cardiovascular Research, Member

Publications

  • Relationship between microRNA-145 and vascular smooth muscle cells senescence in diabetes

    KE Hemmings, K Riches-Suman, NA Turner, KE Porter, DJ O’Regan (2018) British Society for Cardiovascular Research. 104

  • A proinflammatory environment modulates the human dermal fibroblast secretory phenotype: Implications for chronic wounds

    Al-Rikabi A;Riches-Suman K;Tobin DJ;Thornton MJ (2018) British Society for Investigative Dermatology. 178

  • Tumour necrosis factor-a modulates the human dermal fibroblast phenotype: implications for inflammation, impaired wound healing and ageing

    A Al-Rikabi, K Riches, DJ Tobin, MJ Thornton (2017) British Society for Investigative Dermatology. 176

  • Moderate versus heavy intensity interval training for vascular health in post-menopausal women: A paradox!

    KM Birch, E Harris, GK Burk, GK Lyall, K Riches, C Ferguson, KE Porter (2016) American College of Sports Medicine. 48

  • Role of miR-145 as a mediator of DNA damage and senescence in vascular smooth muscle cells from Type 2 diabetes patients

    KE Hemmings, K Riches, DJ O’Regan, NA Turner, KE Porter (2016) British Society for Cardiovascular Research. 102

  • MicroRNA-21 promoted matrix metalloproteinase-1 expression but does not modulate vascular smooth muscle cell invasion

    A Alshanwani, K Riches, IC Wood, NA Turner, KE Porter (2015) European Vascular Biology Organisation. 52

  • Premature aging and DNA damage in smooth muscle cells from type 2 diabetes patients: Role of microRNA-145

    K Riches, DJ O’Regan, KE Porter (2015) European Vascular Biology Organisation. 52

  • Temporal evaluation of SMC phenotype and function in a bioreactor model of abdominal aortic aneurysm (AAA)

    E Clark, K Riches, L Jennings, KE Porter (2015) European Vascular Biology Organisation. 52

  • Transforming growth factor beta drives a distinct diabetes phenotype in human saphenous vein smooth muscle cells via upregulation of microRNA-143/145

    K Riches, IC Wood, NA Turner, KE Porter (2014) British Society for Cardiovascular Research. 100

  • Exploring the role of microRNA-21 on human saphenous vein smooth muscle cell function

    A Alshanwani, K Riches, IC Wood, NA Turner, KE Porter (2014) British Society for Cardiovascular Research. 100

  • Insulin-like growth factor binding protein-1 enhances vascular endothelial repair in the setting of insulin resistance

    A Aziz, N Yuldasheva, J Smith, K Riches, M Gage, RS Mughal, BN Mercer, A Sengupta, N Ali, P Cordell, N Haywood, RM Cubbon, MT Kearney, KE Porter, SB Wheatcroft (2014) British Society for Cardiovascular Research. 100

  • High susceptibility of human abdominal aortic aneurysm (AAA) vascular smooth muscle cells (VSMC) to apoptosis

    MA Bailey, K Riches, DJA Scott, DJ Beech, KE Porter (2014) Society for Academic Research Surgery. 101

  • The use of time-lapse ptychography to measure angiogenesis assay dynamics

    R Suman, K Langley, K Riches, KE Porter, P O’Toole (2014) American Society for Cell Biology. 2014

  • Utilising a bioreactor to evaluate smooth muscle cell phenotype and function in protease treated porcine artery model of AAA disease

    GS Mudhar, K Riches, P Walker, S Sohrabi, DJA Scott, KE Porter (2013) Society for Academic Research Surgery. 100

  • Elevated expression levels of microRNA-143/145 drive aberrant smooth muscle cell phenotype and function in Type 2 diabetes - evidence of metabolic memory

    K Riches, NA Turner, DJ O’Regan, IC Wood, KE Porter (2013) International Union of Physiological Sciences. 2013

  • Human aneurysmal vascular smooth muscle cell activation by oxidized phospholipid and inhibition by pyrazole-2

    BL Green, KL Brodie, R Bon, Y Majeed, K Riches, DJA Scott, KE Porter, DJ Beech (2012) Society for Academic Research Surgery. 99

  • Aberrant regulation of RhoA and cytoskeletal derangement in saphenous vein smooth muscle cells derived from patients with Type 2 Diabetes: a potential role for microRNAs?

    K Riches, P Warburton, DJ O’Regan, SG Ball, NA Turner, IC Wood, KE Porter (2012) Frontiers in Cardiovascular Biology. 93

  • Apoliprotein(a) impairs vascular smooth muscle cell motility via alpha V beta 3 integrin and RhoA activation

    K Riches, L Franklin, A Maqbool, J Bond, ML Koschinsky, DJ O’Regan, SG Ball, NA Turner, KE Porter (2012) Frontiers in Cardiovascular Biology. 93

  • Atypical smooth muscle cell morphology and function in abdominal aortic aneurysms

    TG Angelini, P Warburton, K Riches, DJA Scott, KE Porter (2012) International Surgical Congress of the Association of Surgeons of Great Britain and Ireland. 99

  • Atypical smooth muscle cell morphology and function in abdominal aortic aneurysms

    TG Angelini, P Warburton, K Riches, DJA Scott, KE Porter (2012) Society for Academic Research Surgery. 99

  • Apoliprotein(a) impairs adaptive remodelling in human saphenous vein endothelial and smooth muscle cells

    K Riches, L Franklin, R Chowdhury, A Maqbool, DJ O’Regan, SG Ball, ML Koschinsky, NA Turner, KE Porter (2010) British Society for Cardiovascular Research. 96

  • Hypoxic inhibition of MMP-2 activation and invasion in human cardiac myofibroblasts

    K Riches, ME Morley, C Peers, KE Porter (2008) International Society for Heart Research. 44

  • Hypoxia inhibits MMP-2 activation and invasion in human cardiac myofibroblasts

    K Riches, ME Morley, C Peers, KE Porter (2008) British Society for Cardiovascular Research. 94

  • Furin regulates hypoxic inhibition of MMP-2 activation in human cardiac fibroblasts

    K Riches, ME Morley, C Peers, KE Porter (2007) British Society for Matrix Biology. 88

  • CCAAT enhancer binding proteins as candidate transcription factors in the regulation of features of the insulin resistance syndrome

    AM Carter, CE Bennett, JA Bostock, CM Cymbalista, MS Freeman, TS Futers, K Riches, DJ Rolton, TJ Scarrott, PJ Grant (2005) European Association for the Study of Diabetes. 48

  • CCAAT enhancer binding proteins: co-regulators of haemostasis and the metabolic syndrome?

    AM Carter, CE Bennett, JA Bostock, CM Cymbalista, MS Freeman, TS Futers, K Riches, DJ Rolton, TJ Scarrott, PJ Grant (2005) International Society on Thrombosis and Haemostasis Congress. 3

  • North of England Cell Biology Forum

    K Riches-Suman (2018) British Society for Cell Biology Magazine.

  • Meeting Report: Cardiovascular Disease and Diabetes

    K Riches and meeting co-organizers (2017) The Biochemist.

  • Autumn Meeting of the British Society for Cardiovascular Research 2016: Cardiovascular Disease and Diabetes

    KE Porter, NA Turner, K Riches (2017) BSCR Bulletin.

  • Vascular smooth muscle cells: phenotype and function in type 2 diabetes

    KE Porter, K Riches (2012) BSCR Bulletin.

  • Cardiovascular 2010: A BSCR Travel Report

    K Riches (2011) BSCR Bulletin.